Additionally, we attempted to use the model to study other pharmacological relevant transport mixtures including the permeation enhancer SNAC and the glucagon-like peptide 1 analog semaglutide (SG) used in the recently FDA approved treatment for type II diabetes (Buckley et al., 2018). The gene discussed is GCG; the disease is type 2 diabetes mellitus.